BCMA-CD19 cCAR T for the Treatment of Refractory Inflammatory Bowel Disease (IBD)

Clinical trial NCT07544160 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07544160
Sponsor: iCell Gene Therapeutics
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Inflammatory Bowel Diseases (IBD)

Start date: 2026-04-07
Primary completion: 2028-04-07
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.